StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Motilal Oswal

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)28 Apr 2026via Institutional / Brokerage Research

Entry₹1,747.3Inferred
Target₹2,025
Total upside +15.89% (call closed)
Stop lossNot given
Exit₹2,02531 Jul 2026, 12:07 pm
Target hit+15.89%0.00%upside left
Follow Motilal Oswal for new calls(62% target hit, 1113 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 15 active Long-term calls on SUNPHARMASee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Jul 2026
8 supporting3 neutral1 opposing
Supports the BUY call (8)

4 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·30 Jul · today

Sun Pharma has received approval to manufacture and market semaglutide in Brazil, indicating a potential market expansion and new product offering.

BSE · Company Update·29 Jul · yesterday

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·29 Jul · 2d ago

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 1w ago

(opens in new tab)

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Motilal Oswal

Every call and its outcome